These findings indicate that the additional number of oocytes recovered from PCOS patients may compensate for the poten-
1 To whom correspondence should be addressed patients interfere with folliculogenesis, resulting in poor-quality oocytes and contributing to the reduced fertilization rates and The present study was designed to compare the cycle increased rate of spontaneous abortion (Stanger et al., 1985 ; characteristics of in-vitro fertilization (IVF) and the Howels et al., 1986; Regan et al., 1990) . Homburg et al. chromosomal normality of oocytes in patients with poly- (1993) demonstrated that prevention of premature luteinization cystic ovarian syndrome (PCOS) with those of patients or reduction of tonic LH concentrations by using gonadowith tubal factor infertility. In all, 28 cycles of 24 PCOS trophin-releasing hormone agonist (GnRHa) improved both patients and 55 cycles of 31 patients with tubal factor the fertilization and pregnancy rates in PCOS patients compared infertility (control) were investigated. Although a significwith cycles receiving gonadotrophin only. However, Dor et al. antly greater number of oocytes were retrieved from PCOS (1992) demonstrated that administration of GnRHa in patients patients (mean Ϯ SD: 15.6 Ϯ 6.4 versus 9.0 Ϯ 4.0, PCOS with PCOS did not affect the IVF results and suggested that versus control group, P Ͻ 0.05), the percentage of fertilized development of poor-quality oocytes in PCOS patients may oocytes was significantly lower in the PCOS group combe attributable to reduced fertilization rates. pared with controls (40.1 versus 73.8%, P Ͻ 0.01). The
This evidence raises the possibility that chromosomal aberrapregnancy rate per embryo transfer did not differ between tions of the oocytes obtained from PCOS patients may result the two groups. Cytogenetic analysis was performed on 74 in poor fertilization rates. The present study was designed to oocytes from PCOS patients and 73 oocytes from control investigate the chromosomal normality of unfertilized oocytes patients. In the PCOS group, 10 of the 74 oocytes (13.5%) derived from patients with PCOS and, specifically, the differdemonstrated aneuploidy, four (5.4%) oocytes were diploid ences in the incidence of chromosomal aberrations between and six (8.1%) oocytes were metaphase II with a premathe oocytes obtained from PCOS and those from tubal factor turely condensed sperm chromosome (PCC). In the tubal infertility patients. infertility group, nine of the 73 (12.3%) oocytes showed aneuploidy, four (5.5%) oocytes were diploid and five (6.8%) oocytes were found to have PCC. There was no Materials and methods significant difference in the aneuploidy, diploidy and PCC The study group was selected from patients who underwent IVF rates between the two groups. These results suggest that the treatment between July 1993 and July 1995. Informed consent was reduced fertilization observed in PCOS is not attributable obtained from all patients. In all, 28 cycles in 24 PCOS patients were to chromosomal aberrations or immaturity of oocytes included in this study. PCOS was defined as having typical ultrasound recruited from patients with PCOS.
criteria (a hyperechogenic central stroma and at least 10 follicles of Introduction tubal factor infertility. They were age-matched with patients in the PCOS group. Patients whose partner had abnormal semen quality
In-vitro fertilization (IVF) with embryo transfer has proven to were excluded from the study. Clinical characteristics of the patients be an effective therapy for polycystic ovarian syndrome in the PCOS and control groups are shown in Table I Urman et al., 1992) . It has also been demonstrated that Japan, Tokyo, Japan) and human menopausal gonadotrophin (HMG, significantly more oocytes are recovered from PCOS patients Pergonal; Teikokuzouki, Tokyo, Japan). Suprecur was administered compared with those with other infertility factors (Homburg on day 2 after menstrual or withdrawal bleeding followed by injection of HMG after ovarian down-regulation was ascertained. The dose of et al., 1993; MacDougall et al., 1993; Kodama et al., 1995) . a P Ͻ 0.05 for difference between the PCOS and tubal factor groups. b P Ͻ 0.01 for difference between the PCOS and tubal factor groups.
HMG was individually adjusted according to ovarian response. When ) a significantly greater number of oocytes was retrieved in the PCOS group (P Ͻ 0.05), the percentage of fertilized oocytes oocytes were metaphase II with an additional set of prematurely condensed sperm chromosomes at the G 1 phase (PCC). In one was significantly lower in the PCOS group compared with the controls (P Ͻ 0.01). The pregnancy rate per embryo transfer case, PCC was accompanied by diploidy. In the tubal infertility group, nine of 73 (12.3%) oocytes were aneuploid, including or per patient did not differ between the two groups. Similarly, four (5.5%) hyperploid and five (6.8%) hypoploid, and four with a high ovarian response to gonadotrophin, the cohort of (5.5%) oocytes were found to be diploid. There were five multiple follicles recruited represents follicles in the early (6.8%) oocytes with PCC. There was no significant difference stages of development (Tarin et al., 1990) . In contrast, the in the incidence of aneuploidy, diploidy or PCC between cohort of follicles recruited in PCOS patients seems to comprise oocytes from patients with PCOS or tubal factor infertility.
follicles at more mature stages of development. The multiple follicles associated with PCOS are simply arrested at the small antral stage, being neither atretic nor apoptotic and following Discussion normal development after stimulation by gonadotrophin Several reports have suggested reduced fertilization rates and (Fauser, 1994) . Hardy et al. (1995) also reported that embryos an increased incidence of spontaneous abortion in women with from PCOS patients under an optimized ovulation induction PCOS when compared with patients with tubal factor infertility, regimen were of good quality and developmental potential. although these reports have been conflicting (Dor et al., 1990;  These concepts may explain the difference in the incidence of Urman et al., 1992; Homburg et al., 1993; Hardy et al., 1995) .
immature oocytes between PCOS and high responder groups. The mean number of embryos transferred and the pregnancy Another reason for the absence of any difference in the rates do not differ between PCOS and other infertility patients, incidence of diploid oocytes in PCOS and control patients because the significantly greater number of oocytes recovered may be the similarity of the ages of the patients in the from PCOS patients compensates for the lower fertilization two groups in our study. Roberts and O'Neill (1995) have rate (MacDougall et al., 1993; Kodama et al., 1995; Buyalos demonstrated that the proportion of diploid oocytes increases and Lee, 1996) . Elevated concentrations of LH in the follicular significantly with advancing maternal age, being particularly phase have been reputed to have a crucial role in reduced prevalent in women aged Ͼ35 years. fertilization rates as well as pregnancy wastage in PCOS, since It has been suggested that diploid oocytes originate following the reduction in LH induced by GnRHa administration is disruption of the endocrine control of meiosis, resulting in associated with improved fertilization rates (Homburg et al., impaired extrusion of the first polar body (Hansmann et al., 1993) . In addition, Ashkenazi et al. (1995 Ashkenazi et al. ( ) demonstrated that 1983 . Although the pathogenesis of PCOS is still unclear, the oocytes of patients with PCOS who were exposed to elevated concentrations of LH, insulin resistance and overGnRHa had a significantly higher implantation rate than those production of androgens are associated with this syndrome from patients treated with FSH and HMG alone in oocyte (Kazer et al., 1989; Buyalos et al., 1992; Homburg et al., retrieval cycles. In our present study, we confirmed that a 1996). Elevated free insulin-like growth factor (IGF) and significantly greater number of oocytes, with lower fertilization decreased IGF-binding protein-1 (IGFBP-1) concentrations in rates, were recruited in the PCOS group compared with the combination with LH may stimulate androgen production in tubal factor infertility group, even though all patients were PCOS patients through dysregulation of P450c 17α activity treated with a GnRHa long protocol.
( Rosenfield et al., 1990) . Based on the present results, this It has been demonstrated that decreased fertilization and endocrine disruption, including possible effects on the growth implantation rates are observed in patients who are high hormone (GH)/IGF-1 system, may be mediated either via a responders to gonadotrophins (Pellicer et al., 1989) . Tarin modified accumulation of RNA or through the response of et al. (1990) reported that a significantly greater incidence of granulosa cells to FSH during oocyte growth (Hardy et al., diploidy and of PCC was found in women where Ͼ11 oocytes 1995) . It is unlikely, however, to influence either the meiotic were obtained, compared with women with a moderate response maturity or the chromosomal normality of oocytes. This finding to gonadotrophins, although the total incidence of chromosomal is, in part, supported by recent observations that a high abnormalities was not different between the groups. This incidence of miscarriage in PCOS patients is not correlated finding suggests a higher degree of cytoplasmic immaturity as with fetal chromosomal abnormality (Hasegawa et al., 1996 ) the number of oocytes recruited increases, since PCC and and that, with an optimized ovulation induction, oocytes from diploidy are considered to be characteristic of oocytes with PCOS patients are of good quality (Hardy et al., 1995) . The immature cytoplasm (Badrenas et al., 1989; Calafell et al., reason for lower fertilization in oocytes from PCOS patients 1991). Tarin et al. (1991) also demonstrated a lower rate of was not determined in the present study but may be related to diploid oocytes from fertile control women compared with our ovulation induction protocol. A suboptimal ovulation inseminated unfertilized oocytes from infertile women, regimen may lead to the development of a hyperandrogenic although the incidence of aneuploidy was not different between intrafollicular milieu or to elevated concentrations of LH in the two groups. This suggested that a lower fertilization rate PCOS patients, as suggested by Hardy et al. (1995) , who could be the consequence of oocyte immaturity. Thus, some demonstrated that suboptimal ovulation induction may have a selection against immature oocytes may occur at fertilization. detrimental effect on oocyte quality. The mechanism by which Any selection against aneuploid oocytes seems to be very weak.
endocrine disruption causes impairment of oocyte quality is Taken together, it can be speculated that the observed low not well understood. It has been postulated that LH induces fertilization rates of oocytes from PCOS patients may be premature meiotic maturation of oocytes (Abdulwahid et al., attributable to the high incidence of immature oocytes recruited.
1985) and may cause detrimental prolongation of the interval However, the present findings demonstrated that there were between completion of first meiosis and fertilization. In addino differences in the incidence of metaphase II, diploidy, PCC or aneuploidy between the PCOS and control groups. In cases tion, Anderiesz and Trounson (1995) reported that androgen tonic levels of luteinizing hormone on outcome of in-vitro fertilization.
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